The Herzliya-based company raised nearly $1.9 billion at $27 per share, above the planned range of $22-24 per share.
Explaining the Bank of Israel's decision to buy $30 billion, Andrew Abir spoke of providing certainty and protecting jobs. Market sources: It's a game changer. Economy
CFO Ronen Faier explains the strategy and culture that led SolarEdge to becoming the most valuable Israeli company on Wall Street. Energy
Adelson's lavish support was a mainstay of the political success of both Donald Trump and Benjamin Netanyahu. Politics
The neighborhoods ranked as top quality by Israel's Central Bureau of Statistics have surprisingly reasonable prices. Real estate
Experts are alarmed about possible breaches of confidentiality and the lack of transparency in Israel's vaccine deal with Pfizer. Healthcare
ExoProTher Medical is using the body's own anti-cancer agent to treat brain cancer. Healthcare
International bioethics expert Prof. Vardit Ravitsky weighs the pros and cons of a 'green passport' for those already vaccinated. Healthcare
All eyes will be on Israel to see not only if the jabs work but also if the country can use its success to come smoothly out of lockdown. Healthcare
Yoav Zeif took the helm of 3D printer company Stratasys just before Covid-19 broke out. He tells "Globes" how he used the crisis. IT
An oligarch with $160,000 cash, and a man smuggling $40,000 in fish are among those caught at the airport bringing unreported cash into Israel, the tax authority reports. Legal
NovoCure's innovative cancer treatment has already made it the third most valuable Israeli company on Wall Street. CEO Asaf Danziger talks to "Globes". Healthcare
Covid-19 dealt the conference and events platform developer a seemingly lethal blow but it pivoted swiftly to virtual conferences. Start ups
